Metrics
1 Record Views
- Title
- Oral Abstract: ABCL-022: LOTIS-2 Follow-Up Analysis: Updated Results from a Phase 2 Study of Loncastuximab Tesirine (Lonca) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Creators
- Brad S Kahl - Department of Medicine, Oncology Division, Washington University, St. Louis, MO, USAMehdi Hamadani - Medical College of WisconsinPaolo F Caimi - University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH, USACarmelo Carlo-Stella - Humanitas UniversityWeiyun Ai - University of California, San FranciscoJuan Pablo Alderuccio - University of MiamiKirit M Ardeshna - University College London Hospitals NHS Foundation TrustBrian Hess - Medical University of South CarolinaJohn Radford - University of ManchesterMelhem Solh - Northside HospitalAnastasios Stathis - Oncology Institute of Southern Switzerland, Bellinzona, SwitzerlandJay Feingold - Adc TherapeuticsDavid Ungar - Adc TherapeuticsYajuan Qin - Adc TherapeuticsShui He - Adc TherapeuticsPier Luigi Zinzani - Medicina
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.21, pp.S203-S203
- Publisher
- Elsevier Inc
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031714333102976